Company / SG&A Expense
MEDIFAST INC SG&A Expense History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$289.4M
FY2025
5-year range
$188.2M / $649.4M
FY2021-FY2025
Trend
-34.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $649M to $289M over the past 2 years.
Based on SEC 10-K filings.
$289M in FY2025 with a 10-year CAGR of +3.7%.
Improved from $649M to $289M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- +3.7%
Key checks
Key Insights
- 5-year CAGR of -1.4%, indicating a declining trend.
- In FY2025, sg&a expense decreased 34.5% year-over-year.
- Peak sg&a expense was recorded in FY2023.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $289.4M | -34.5% |
| FY2024 | $441.7M | -32.0% |
| FY2023 | $649.4M | +108.9% |
| FY2020 | $310.8M | +65.2% |
| FY2019 | $188.2M | +5.2% |
| FY2018 | $178.8M | +3.6% |
| FY2017 | $172.6M | -3.5% |
| FY2016 | $179.0M | -11.5% |
| FY2015 | $202.2M | -3.2% |
| FY2014 | $208.8M | +5.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026